Lu Guo

433 total citations
12 papers, 152 citations indexed

About

Lu Guo is a scholar working on Hepatology, Surgery and Cancer Research. According to data from OpenAlex, Lu Guo has authored 12 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 5 papers in Surgery and 4 papers in Cancer Research. Recurrent topics in Lu Guo's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and RNA modifications and cancer (2 papers). Lu Guo is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and RNA modifications and cancer (2 papers). Lu Guo collaborates with scholars based in China and United States. Lu Guo's co-authors include Ke Su, Hao Zeng, Ke Xu, Tao Gu, Kun He, Yunwei Han, Han Li, Hao Chi, Yunwei Han and Jiali Chen and has published in prestigious journals such as Scientific Reports, Lasers in Medical Science and Biology Direct.

In The Last Decade

Lu Guo

11 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Guo China 7 71 46 44 44 40 12 152
Hao Zeng China 8 54 0.8× 37 0.8× 81 1.8× 42 1.0× 60 1.5× 20 206
Carmen Andreu-Oller Spain 2 73 1.0× 44 1.0× 34 0.8× 39 0.9× 34 0.8× 2 125
Wen‐Bin Ding China 6 67 0.9× 77 1.7× 75 1.7× 25 0.6× 49 1.2× 11 199
Kengo Kanayama Japan 7 47 0.7× 25 0.5× 61 1.4× 63 1.4× 45 1.1× 10 160
Cheng‐Qian Zhong China 9 139 2.0× 71 1.5× 95 2.2× 36 0.8× 47 1.2× 20 277
Erik Rasbach Germany 11 74 1.0× 24 0.5× 37 0.8× 50 1.1× 83 2.1× 25 217
Ruibao Liu China 8 42 0.6× 9 0.2× 57 1.3× 39 0.9× 35 0.9× 23 142
Marta Piqué‐Gili United Kingdom 4 75 1.1× 19 0.4× 17 0.4× 26 0.6× 54 1.4× 4 125
Nieves Martínez Lago Spain 8 29 0.4× 18 0.4× 40 0.9× 51 1.2× 121 3.0× 44 165

Countries citing papers authored by Lu Guo

Since Specialization
Citations

This map shows the geographic impact of Lu Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Guo more than expected).

Fields of papers citing papers by Lu Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Guo. The network helps show where Lu Guo may publish in the future.

Co-authorship network of co-authors of Lu Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Guo. A scholar is included among the top collaborators of Lu Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Guo. Lu Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Tian, Min, Yang Cao, Min Tang, et al.. (2024). YTHDC1 aggravates high glucose-induced retinal vascular endothelial cell injury via m6A modification of CDK6. Biology Direct. 19(1). 54–54. 6 indexed citations
3.
Su, Ke, Weihong Huang, Ke Xu, et al.. (2023). Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram. Journal of Hepatocellular Carcinoma. Volume 10. 69–79. 30 indexed citations
5.
Guo, Lu, Zixuan Cheng, Xiangmei Kong, et al.. (2023). The effect of different angle kappa on higher-order aberrations after small incision lenticule extraction. Lasers in Medical Science. 38(1). 277–277. 2 indexed citations
6.
Su, Ke, Tao Gu, Ke Xu, et al.. (2023). Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study. Annals of Hepatology. 28(4). 101109–101109. 30 indexed citations
7.
Li, Han, Lu Guo, Ke Su, et al.. (2023). Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study. Journal of Hepatocellular Carcinoma. Volume 10. 1009–1017. 24 indexed citations
8.
Zeng, Hao, Ke Su, Xiaojing Chen, et al.. (2023). A propensity score matching study on survival benefits of radiotherapy in patients with inoperable hepatocellular carcinoma. Scientific Reports. 13(1). 6879–6879. 3 indexed citations
9.
Chen, Xiaojing, et al.. (2022). Biological Role and Mechanism of Lipid Metabolism Reprogramming Related Gene ECHS1 in Cancer. Technology in Cancer Research & Treatment. 21. 2213882543–2213882543. 14 indexed citations
11.
Li, Han, Jiali Chen, Ke Su, et al.. (2022). External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Clinical and Experimental Medicine. 23(5). 1537–1549. 30 indexed citations
12.
Mao, Xinrui, Hao Chen, Hao Chi, et al.. (2022). Upregulated LINC00922 Promotes Epithelial-Mesenchymal Transition and Indicates a Dismal Prognosis in Gastric Cancer. Journal of Oncology. 2022. 1–17. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026